Paulson & Co 13F, Q4 2023

John Paulson · quarter ending 31 December 2023 · filed 14 February 2024 · SEC CIK 1035674

$1.11B
Filed US book
17
Positions
23.1%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q4 2023

Weights are against the whole filed book. Changes are in shares held, against the Q3 2023 filing.

CompanyTickerValue% of bookvs Q3 2023
MADRIGAL PHARMACEUTICALS INCMDGL$255.85M23.1%+121% shares
BAUSCH HEALTH COS INCBHC$212.04M19.1%unchanged
BRIGHTSPHERE INVT GROUP INCAAMI$171.48M15.5%unchanged
NOVAGOLD RES INCNG$88.05M8.0%+6% shares
PERPETUA RESOURCES CORPPPTA$78.53M7.1%unchanged
ANGLOGOLD ASHANTI PLC$71.65M6.5%unchanged
AGNICO EAGLE MINES LTDAEM$42.98M3.9%unchanged
THRYV HLDGS INCTHRY$40.70M3.7%unchanged
INTERNATIONAL TOWER HILL MINTHM$36.23M3.3%unchanged
NEWMARK GROUP INCNMRK$32.88M3.0%+134% shares
SEABRIDGE GOLD INCSEA1EUR$25.11M2.3%unchanged
SSR MINING INSSRM$21.52M1.9%unchanged
EQUINOX GOLD CORPEQX$12.22M1.1%unchanged
TRILOGY METALS INC NEWTMQ$6.16M0.6%unchanged
IAMGOLD CORPIAG$4.68M0.4%unchanged
TELLURIAN INC NEW$4.04M0.4%unchanged
ALIBABA GROUP HLDG LTDBABA$3.88M0.3%unchanged

What changed since Q3 2023

Against the Q3 2023 filing, Paulson & Co opened 0 new positions, added to 3, trimmed 0, left 14 unchanged and exited 1. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

No new positions this quarter.

Exited

  • HORIZON THERAPEUTICS PUB Lwas $243.30M

Added to

Trimmed

No position was cut by more than 2%.

Other quarters

Source: SEC Form 13F-HR, accession 0001013594-24-000197, filed by PAULSON & CO. INC.. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.